Kovack Advisors’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$227K Sell
2,707
-229
-8% -$18.4K 0.01% 942
2026
Q1
$246K Sell
2,936
-3,510
-54% -$264K 0.01% 832
2025
Q4
$432K Buy
+6,446
New +$417K 0.02% 639
2025
Q3
Sell
-5,928
Closed -$442K 625
2025
Q2
$442K Buy
+5,928
New +$395K 0.04% 366
2021
Q4
Sell
-5,238
Closed -$220K 723
2021
Q3
$220K Sell
5,238
-101
-2% -$4.37K 0.02% 632
2021
Q2
$237K Buy
+5,339
New +$247K 0.03% 588

Other funds holding CTVA

Kovack Advisors's CTVA Position: Q2 2026 in Review

Kovack Advisors reduced its Corteva (CTVA) stake by 7.8% in Q2 2026, selling an estimated $18.4K and leaving 2,707 shares worth $227K. The position accounts for 0.01% of the portfolio, ranked #942.

Kovack Advisors first reported a position in CTVA in Q2 2021 and has held it in 6 quarters since. The position peaked at $442K in Q2 2025. 1,491 funds tracked by Wall St. Rank hold CTVA as of Q2 2026.

  • Kovack Advisors held 2,707 shares of Corteva worth $227K as of Q2 2026.
  • Kovack Advisors sold 229 Corteva shares in Q2 2026, an estimated $18.4K.
  • Corteva made up 0.01% of Kovack Advisors's portfolio in Q2 2026, its #942 holding.
  • Kovack Advisors first reported a position in Corteva in Q2 2021 and has held it in 6 quarters since.
  • Kovack Advisors's Corteva position peaked at $442K in Q2 2025.
  • 1,491 funds tracked by Wall St. Rank held Corteva as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.